Medtronic plc, has chosen the North American Spine Society (NASS) annual meeting at which to announce the U.S. launch of Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™ Surface Technology, a proprietary blend of surface textures on the macro, micro, and nano levels.
The Adaptix Interbody System, mirrored after the veteran Capstone™ Spinal System, touts improved features for increased strength, subsidence resistance, easy insertion, and data-backed bone growth.
This milestone represents the first 3D printed titanium implant, developed in house by Medtronic engineers, that incorporates the state-of-the-art Titan nanoLOCK Surface Technology, Titan Spine having been acquired in 2019.
This surface technology is the first to demonstrate the elements to be considered a nanotechnology for spinal devices as outlined in the FDA nanotechnology guidance document.
“Adaptix Interbody System allows me the best chance to meet my patients’ needs by confidently placing the implant under navigation and trusting the Titan nanoLOCK Surface Technology to allow the implant to promote fusion. Surface technology, material type, and implant design all play a role in bone growth process during fusion,” said J. Justin Seale, M.D. of OrthoArkansas Spine Institute. “The unique features and world-class technologies make the Adaptix Interbody System a truly differentiated implant.”
“Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK Surface Technology,” said Sharrolyn Josse, vice president and general manager of Medtronic Core Spine and Biologics division, which is part of the Restorative Therapies Group at Medtronic. “It is a fully navigated procedure, leveraging our leadership in navigation.”
Source; Medtronic, plc